Related Experiment Videos

Testing The Utility Of The Nhs's Systemic Anti-Cancer Therapy Data Set For Multi-Indication Pricing

L McNamara¹, S McNamara¹

¹Roche Products Ltd., Welwyn Garden City, UK.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research

|May 21, 2016

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Changes in fecal microbiota with CFTR modulator therapy: A pilot study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2021

Best practice guidelines for communicating to parents the diagnosis of disability.

Early human development·2019

Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England.

PharmacoEconomics - open·2018

The 'ins and outs' of faecal microbiota transplant for recurrent Clostridium difficile diarrhoea at Wits Donald Gordon Medical Centre, Johannesburg, South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2018

Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England.

PharmacoEconomics - open·2018

Initial development and pilot testing of observer-reported outcomes (ObsROs) for children with cystic fibrosis ages 0-11years.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2018

See all related articles